Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma. Issue 4 (18th February 2019)
- Record Type:
- Journal Article
- Title:
- Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma. Issue 4 (18th February 2019)
- Main Title:
- Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
- Authors:
- Zhu, Lei
Yin, Guotao
Chen, Wei
Li, Xiaofeng
Yu, Xiaozhou
Zhu, Xiang
Jiang, Wei
Jia, Chaoyang
Chen, Peihe
Zhang, Yufan
Lu, Di
Yu, Lijuan
Li, Xubin
Xu, Wengui - Abstract:
- Abstract : Background: The purpose of this study was to investigate an association between EGFR mutation status and 18 F‐fluorodeoxyglucose positron emission tomography‐computed tomography ( 18 F‐FDG PET‐CT) image features in lung adenocarcinoma. Methods: Retrospective analysis of the data of 139 patients with lung adenocarcinoma confirmed by surgical pathology who underwent preoperative 18 F‐FDG PET‐CT was conducted. Correlations between EGFR mutation status, clinical characteristics, and PET‐CT parameters, including the maximum standardized uptake value (SUVmax), the mean of the SUV (SUVmean), the peak of the SUV (SUVpeak) of the primary tumor, and the ratio of SUVmax between the primary tumor and the mediastinal blood pool (SUVratio), were statistically analyzed. Multivariate logistic regression analysis was performed to identify predictors of EGFR mutation. Receiver operating characteristic curves of statistical quantitative parameters were compared. Results: EGFR mutations were detected in 74 (53.2%) of the 139 lung adenocarcinomas and were more frequent in non‐smoking patients. Univariate analysis showed that the SUVmax, SUVmean, SUVpeak, and SUVratio were lower in EGFR ‐mutated than in wild‐type tumors. The receiver operating characteristic curves showed no significant differences between their diagnostic efficiencies. Multivariate logistic regression analysis showed that being a never smoker was an independent predictor of EGFR mutation. Conclusion: QuantitativeAbstract : Background: The purpose of this study was to investigate an association between EGFR mutation status and 18 F‐fluorodeoxyglucose positron emission tomography‐computed tomography ( 18 F‐FDG PET‐CT) image features in lung adenocarcinoma. Methods: Retrospective analysis of the data of 139 patients with lung adenocarcinoma confirmed by surgical pathology who underwent preoperative 18 F‐FDG PET‐CT was conducted. Correlations between EGFR mutation status, clinical characteristics, and PET‐CT parameters, including the maximum standardized uptake value (SUVmax), the mean of the SUV (SUVmean), the peak of the SUV (SUVpeak) of the primary tumor, and the ratio of SUVmax between the primary tumor and the mediastinal blood pool (SUVratio), were statistically analyzed. Multivariate logistic regression analysis was performed to identify predictors of EGFR mutation. Receiver operating characteristic curves of statistical quantitative parameters were compared. Results: EGFR mutations were detected in 74 (53.2%) of the 139 lung adenocarcinomas and were more frequent in non‐smoking patients. Univariate analysis showed that the SUVmax, SUVmean, SUVpeak, and SUVratio were lower in EGFR ‐mutated than in wild‐type tumors. The receiver operating characteristic curves showed no significant differences between their diagnostic efficiencies. Multivariate logistic regression analysis showed that being a never smoker was an independent predictor of EGFR mutation. Conclusion: Quantitative parameters based on 18 F‐FDG PET‐CT have modest power to predict the presence of EGFR mutation in lung adenocarcinoma; however, when compared to smoking history, they are not good or significant predictive factors. … (more)
- Is Part Of:
- Thoracic cancer. Volume 10:Issue 4(2019)
- Journal:
- Thoracic cancer
- Issue:
- Volume 10:Issue 4(2019)
- Issue Display:
- Volume 10, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 10
- Issue:
- 4
- Issue Sort Value:
- 2019-0010-0004-0000
- Page Start:
- 659
- Page End:
- 664
- Publication Date:
- 2019-02-18
- Subjects:
- 18F‐FDG -- EGFR mutation -- lung cancer -- PET/CT
Chest -- Cancer -- Periodicals
Chest -- Cancer -- Treatment -- Periodicals
Chest -- Surgery -- Periodicals
616.99494005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291759-7714;jsessionid=9202029487E02D838DF722140677202D.d04t01 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1759-7714 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.wiley.com/bw/journal.asp?ref=1759-7706&site=1 ↗ - DOI:
- 10.1111/1759-7714.12981 ↗
- Languages:
- English
- ISSNs:
- 1759-7706
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8820.242500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12399.xml